BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 25419715)

  • 1. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
    Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
    PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.
    Jovčevska I; Zupanec N; Urlep Ž; Vranič A; Matos B; Stokin CL; Muyldermans S; Myers MP; Buzdin AA; Petrov I; Komel R
    Oncotarget; 2017 Jul; 8(27):44141-44158. PubMed ID: 28498803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.
    De Vlaminck K; Romão E; Puttemans J; Pombo Antunes AR; Kancheva D; Scheyltjens I; Van Ginderachter JA; Muyldermans S; Devoogdt N; Movahedi K; Raes G
    Front Immunol; 2021; 12():777524. PubMed ID: 34917090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
    Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
    Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma-specific anti-TUFM nanobody for
    Samec N; Jovcevska I; Stojan J; Zottel A; Liovic M; Myers MP; Muyldermans S; Šribar J; Križaj I; Komel R
    Oncotarget; 2018 Apr; 9(25):17282-17299. PubMed ID: 29707108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.
    Porčnik A; Novak M; Breznik B; Majc B; Hrastar B; Šamec N; Zottel A; Jovčevska I; Vittori M; Rotter A; Komel R; Lah Turnšek T
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
    Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
    J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.
    Zorniak M; Clark PA; Kuo JS
    J Neurosurg; 2015 Jan; 122(1):69-77. PubMed ID: 25361488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
    Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
    J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.
    Trépant AL; Bouchart C; Rorive S; Sauvage S; Decaestecker C; Demetter P; Salmon I
    Tumour Biol; 2015 Mar; 36(3):1943-53. PubMed ID: 25384509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
    Ji L; Dong C; Fan R; Qi S
    Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
    Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.